| Pedro Campos, | |
|
15324 Palm Leaf Ln, Fontana, CA 92336-3336 | |
| (323) 807-2654 | |
| Not Available |
| Full Name | Pedro Campos |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 15324 Palm Leaf Ln, Fontana, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013307354 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 6179 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pedro Campos, 15324 Palm Leaf Ln, Fontana, CA 92336-3336 Ph: () - | Pedro Campos, 15324 Palm Leaf Ln, Fontana, CA 92336-3336 Ph: (323) 807-2654 |
News Archive
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
Inviting researchers to attend institutional review board sessions designed to approve these same investigators' requests to conduct research involving human subjects doesn't seem to affect the efficiency of the process one way or the other, a new study led by Johns Hopkins bioethicists suggests.
Health researchers in Cambridge have been awarded £114.5m to develop and translate new scientific discoveries into medicines and treatments. The funds come as a part of a five-year £800m investment by the National Institute for Health Research (NIHR).
An experimental compound synthesized and developed by scientists from the Florida campus of The Scripps Research Institute has the capacity to significantly reduce joint inflammation in animal models of rheumatoid arthritis, an autoimmune disease that affects more than two million Americans.
Verde Media Group Inc. and its Biotech Division announce they have completed the acquisition of the privately held biotechnology company Butazyme LLC.
› Verified 4 days ago
Mrs. Kathryn Mary Foster, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-4073 | |
Patricia Lotich, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9985 Sierra Ave, Fontana, CA 92335 Phone: 909-427-6996 | |
Mr. Gerald Arafol, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9985 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3945 | |
Alice Wong, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 888-232-3030 | |
Margaret Mclaughlin, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9985 Sierra Ave, Fontana, CA 92335 Phone: 909-427-6996 | |
Hazel Marlene Carter, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-6939 |